Next-Generation In-Silico Computational Chemistry & Data-Engineering Pipelines

Elym Discovery is developing computational frameworks to automate predictive bioactivity modelling and taxonomic characterisation for the global oral and dental healthcare therapeutics sector. Our secure, computer-implemented data pipelines are designed to process text-based genomic marker data, with the aim of accelerating formulation timelines and reducing reliance on traditional wet-lab screening.

Projects

Two Phases

Phase 1: In-Silico Bioactivity Profiling -

Intended to help smaller brands prioritise promising natural-product candidates computationally before committing to costly CRO validation.

Phase 2: Multi-Omics R&D Scaling -

Intended to support more advanced research needs within the oral and dental healthcare sectors, including the investigation of formulation, toxicity and other candidate-development considerations.